Tag: obesity treatment
Eli Lilly Set to Overtake Novo Nordisk in Weight-Loss Drug Race by 2025
- Nov, 24 2025
- 0
Eli Lilly is projected to overtake Novo Nordisk in the GLP-1 drug market by 2025, with Zepbound and Mounjaro sales surpassing $10 billion in Q3, while Novo Nordisk faces supply shortages, falling stock, and declining growth amid shifting patient preferences.
Categories
- Sports News & Analysis (4)
- Sports (3)
- Women's Sports (2)
- Business (2)
- Health and Wellness (1)
- Tennis Equipment (1)
- Tennis Players (1)
- Musical Instrument Health & Safety (1)
- Sports Equipment Retailers (1)
- Tennis Equipment Reviews (1)